!!python/object/apply:collections.defaultdict
args: [!!python/name:__builtin__.list '']
dictitems:
  AP32788:
  - {Alteration: Exon 20 insertions, Gene: ERBB2, Level: '4', Subtype: Non-Small Cell
      Lung Cancer}
  - {Alteration: Exon 20 insertions/deletions, Gene: ERBB2, Level: '4', Subtype: Non-Small
      Cell Lung Cancer}
  - {Alteration: S768I, Gene: EGFR, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: Exon 20 insertion, Gene: EGFR, Level: '4', Subtype: Non-Small Cell
      Lung Cancer}
  - {Alteration: L861R, Gene: EGFR, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: G719A, Gene: EGFR, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  AZD-4575:
  - &id004 {Alteration: K650E, Gene: FGFR3, Level: 3A, Subtype: Bladder Cancer}
  - &id005 {Alteration: S249C, Gene: FGFR3, Level: 3A, Subtype: Bladder Cancer}
  - &id006 {Alteration: S371C, Gene: FGFR3, Level: 3A, Subtype: Bladder Cancer}
  - &id007 {Alteration: Y373C, Gene: FGFR3, Level: 3A, Subtype: Bladder Cancer}
  - &id008 {Alteration: K650R, Gene: FGFR3, Level: 3A, Subtype: Bladder Cancer}
  - &id009 {Alteration: K650N, Gene: FGFR3, Level: 3A, Subtype: Bladder Cancer}
  - &id010 {Alteration: K650Q, Gene: FGFR3, Level: 3A, Subtype: Bladder Cancer}
  - &id011 {Alteration: K650M, Gene: FGFR3, Level: 3A, Subtype: Bladder Cancer}
  - &id012 {Alteration: K650T, Gene: FGFR3, Level: 3A, Subtype: Bladder Cancer}
  - &id013 {Alteration: R248C, Gene: FGFR3, Level: 3A, Subtype: Bladder Cancer}
  - &id014 {Alteration: G370C, Gene: FGFR3, Level: 3A, Subtype: Bladder Cancer}
  - &id015 {Alteration: G380R, Gene: FGFR3, Level: 3A, Subtype: Bladder Cancer}
  AZD4547:
  - &id016 {Alteration: Fusions, Gene: FGFR3, Level: 3A, Subtype: Bladder Cancer}
  - &id017 {Alteration: Amplification, Gene: FGFR1, Level: 3A, Subtype: Lung Squamous
      Cell Carcinoma}
  AZD4575:
  - &id002 {Alteration: Fusions, Gene: FGFR2, Level: 3A, Subtype: Bladder Cancer}
  - &id003 {Alteration: Fusions, Gene: FGFR2, Level: 3A, Subtype: Cholangiocarcinoma}
  AZD5363:
  - {Alteration: E17K, Gene: AKT1, Level: 3A, Subtype: Endometrial Cancer}
  - {Alteration: E17K, Gene: AKT1, Level: 3A, Subtype: Breast Cancer}
  - {Alteration: E17K, Gene: AKT1, Level: 3A, Subtype: Ovarian Cancer}
  AZD6482 + Alpelisib:
  - {Alteration: Oncogenic Mutations, Gene: PTEN, Level: '4', Subtype: Breast Cancer}
  AZD8186:
  - &id067 {Alteration: Oncogenic Mutations, Gene: PTEN, Level: '4', Subtype: All
      Tumors}
  AZD9496:
  - &id066 {Alteration: Oncogenic Mutations, Gene: ESR1, Level: 3A, Subtype: Breast
      Cancer}
  Abemaciclib:
  - &id077 {Alteration: Amplification, Gene: CDK4, Level: 2A, Subtype: Dedifferentiated
      Liposarcoma}
  - &id078 {Alteration: Amplification, Gene: CDK4, Level: 2A, Subtype: Well-Differentiated
      Liposarcoma}
  Ado-Trastuzumab Emtansine:
  - &id072 {Alteration: Amplification, Gene: ERBB2, Level: '1', Subtype: Breast Cancer}
  Afatinib:
  - &id047 {Alteration: S768I, Gene: EGFR, Level: '1', Subtype: Non-Small Cell Lung
      Cancer}
  - &id048 {Alteration: L833V, Gene: EGFR, Level: '1', Subtype: Non-Small Cell Lung
      Cancer}
  - &id049 {Alteration: L858R, Gene: EGFR, Level: '1', Subtype: Non-Small Cell Lung
      Cancer}
  - &id050 {Alteration: G719A, Gene: EGFR, Level: '1', Subtype: Non-Small Cell Lung
      Cancer}
  - &id051 {Alteration: E709K, Gene: EGFR, Level: '1', Subtype: Non-Small Cell Lung
      Cancer}
  - &id052 {Alteration: A750P, Gene: EGFR, Level: '1', Subtype: Non-Small Cell Lung
      Cancer}
  - &id053 {Alteration: G719C, Gene: EGFR, Level: '1', Subtype: Non-Small Cell Lung
      Cancer}
  - &id054 {Alteration: T790M, Gene: EGFR, Level: R1, Subtype: Non-Small Cell Lung
      Cancer}
  - &id055 {Alteration: EGFR-KDD Fusion, Gene: EGFR, Level: '1', Subtype: Non-Small
      Cell Lung Cancer}
  - &id056 {Alteration: Exon 20 insertion, Gene: EGFR, Level: R1, Subtype: Non-Small
      Cell Lung Cancer}
  - &id057 {Alteration: Exon 19 insertion, Gene: EGFR, Level: '1', Subtype: Non-Small
      Cell Lung Cancer}
  - &id058 {Alteration: Exon 19 deletion/insertion, Gene: EGFR, Level: '1', Subtype: Non-Small
      Cell Lung Cancer}
  - &id059 {Alteration: Exon 19 deletion, Gene: EGFR, Level: '1', Subtype: Non-Small
      Cell Lung Cancer}
  - &id060 {Alteration: L861R, Gene: EGFR, Level: '1', Subtype: Non-Small Cell Lung
      Cancer}
  - &id061 {Alteration: A763_Y764insFQEA, Gene: EGFR, Level: '1', Subtype: Non-Small
      Cell Lung Cancer}
  - &id062 {Alteration: E709_T710delinsD, Gene: EGFR, Level: '1', Subtype: Non-Small
      Cell Lung Cancer}
  - &id063 {Alteration: L747P, Gene: EGFR, Level: '1', Subtype: Non-Small Cell Lung
      Cancer}
  - &id064 {Alteration: L861Q, Gene: EGFR, Level: '1', Subtype: Non-Small Cell Lung
      Cancer}
  - &id065 {Alteration: G719S, Gene: EGFR, Level: '1', Subtype: Non-Small Cell Lung
      Cancer}
  Alectinib:
  - &id020 {Alteration: Fusions, Gene: ALK, Level: '1', Subtype: Non-Small Cell Lung
      Cancer}
  Alpelisib:
  - &id001 {Alteration: Oncogenic Mutations, Gene: PIK3CA, Level: 3A, Subtype: Breast
      Cancer}
  Alpelisib + Fulvestrant:
  - *id001
  Avapritinib:
  - &id033 {Alteration: D816A, Gene: KIT, Level: '4', Subtype: Gastrointestinal Stromal
      Tumor}
  - &id034 {Alteration: D816H, Gene: KIT, Level: '4', Subtype: Gastrointestinal Stromal
      Tumor}
  - &id035 {Alteration: D816F, Gene: KIT, Level: '4', Subtype: Gastrointestinal Stromal
      Tumor}
  - &id036 {Alteration: D816Y, Gene: KIT, Level: '4', Subtype: Gastrointestinal Stromal
      Tumor}
  - &id037 {Alteration: D816N, Gene: KIT, Level: '4', Subtype: Gastrointestinal Stromal
      Tumor}
  - &id038 {Alteration: D816V, Gene: KIT, Level: '4', Subtype: Gastrointestinal Stromal
      Tumor}
  - &id039 {Alteration: D816G, Gene: KIT, Level: '4', Subtype: Gastrointestinal Stromal
      Tumor}
  - &id040 {Alteration: D816E, Gene: KIT, Level: '4', Subtype: Gastrointestinal Stromal
      Tumor}
  BGJ-398:
  - *id002
  - *id003
  - *id004
  - *id005
  - *id006
  - *id007
  - *id008
  - *id009
  - *id010
  - *id011
  - *id012
  - *id013
  - *id014
  - *id015
  BGJ398:
  - *id016
  - *id017
  BVD-523:
  - &id071 {Alteration: Oncogenic Mutations, Gene: BRAF, Level: '4', Subtype: All
      Tumors}
  BVD523:
  - &id018 {Alteration: Oncogenic Mutations, Gene: NF1, Level: '4', Subtype: All Tumors}
  Binimetinib:
  - &id105 {Alteration: Oncogenic Mutations, Gene: KRAS, Level: '4', Subtype: Non-Small
      Cell Lung Cancer}
  - &id019 {Alteration: Oncogenic Mutations, Gene: NRAS, Level: 3A, Subtype: Melanoma}
  - *id018
  Binimetinib + Ribociclib:
  - *id019
  Brigatinib:
  - *id020
  Buparlisib:
  - *id001
  Buparlisib + Fulvestrant:
  - *id001
  Cabozantinib:
  - {Alteration: Fusions, Gene: RET, Level: 2A, Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: Amplification, Gene: MET, Level: 2A, Subtype: Renal Cell Carcinoma}
  - &id021 {Alteration: Y1003N, Gene: MET, Level: 3A, Subtype: Non-Small Cell Lung
      Cancer}
  - &id022 {Alteration: D1010H, Gene: MET, Level: 3A, Subtype: Non-Small Cell Lung
      Cancer}
  - &id023 {Alteration: X1009_splice, Gene: MET, Level: 3A, Subtype: Non-Small Cell
      Lung Cancer}
  - &id024 {Alteration: D1010N, Gene: MET, Level: 3A, Subtype: Non-Small Cell Lung
      Cancer}
  - &id025 {Alteration: 963_D1010splice, Gene: MET, Level: 3A, Subtype: Non-Small
      Cell Lung Cancer}
  - &id026 {Alteration: X963_splice, Gene: MET, Level: 3A, Subtype: Non-Small Cell
      Lung Cancer}
  - &id027 {Alteration: X1008_splice, Gene: MET, Level: 3A, Subtype: Non-Small Cell
      Lung Cancer}
  - &id028 {Alteration: D1010Y, Gene: MET, Level: 3A, Subtype: Non-Small Cell Lung
      Cancer}
  - &id029 {Alteration: X1006_splice, Gene: MET, Level: 3A, Subtype: Non-Small Cell
      Lung Cancer}
  - &id030 {Alteration: 981_1028splice, Gene: MET, Level: 3A, Subtype: Non-Small Cell
      Lung Cancer}
  - &id031 {Alteration: X1007_splice, Gene: MET, Level: 3A, Subtype: Non-Small Cell
      Lung Cancer}
  Capmatinib:
  - *id021
  - *id022
  - *id023
  - *id024
  - *id025
  - *id026
  - *id027
  - *id028
  - *id029
  - *id030
  - *id031
  Ceritinib:
  - &id032 {Alteration: Fusions, Gene: ALK, Level: 2A, Subtype: Inflammatory Myofibroblastic
      Tumor}
  - *id020
  Cetuximab:
  - &id079 {Alteration: Wildtype, Gene: KRAS, Level: '1', Subtype: Colorectal Cancer}
  - &id080 {Alteration: Oncogenic Mutations, Gene: KRAS, Level: R1, Subtype: Colorectal
      Cancer}
  - &id081 {Alteration: Oncogenic Mutations, Gene: NRAS, Level: R1, Subtype: Colorectal
      Cancer}
  Cisplatin:
  - {Alteration: Oncogenic Mutations, Gene: ERCC2, Level: 3A, Subtype: Bladder Cancer}
  Cobimetinib:
  - &id106 {Alteration: Fusions, Gene: BRAF, Level: 3A, Subtype: Ovarian Cancer}
  - &id107 {Alteration: Fusions, Gene: BRAF, Level: 3A, Subtype: Melanoma}
  - &id108 {Alteration: Oncogenic Mutations, Gene: MAP2K1, Level: 3A, Subtype: Melanoma}
  - &id109 {Alteration: Oncogenic Mutations, Gene: MAP2K1, Level: 3A, Subtype: Low-Grade
      Serous Ovarian Cancer}
  - &id110 {Alteration: Oncogenic Mutations, Gene: MAP2K1, Level: 3A, Subtype: Non-Small
      Cell Lung Cancer}
  - &id111 {Alteration: Oncogenic Mutations, Gene: MAP2K1, Level: 3A, Subtype: Histiocytic
      Disorder}
  Copanlisib:
  - *id001
  Crizotinib:
  - {Alteration: D1010H, Gene: MET, Level: 2A, Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: 963_D1010splice, Gene: MET, Level: 2A, Subtype: Non-Small Cell Lung
      Cancer}
  - {Alteration: X1007_splice, Gene: MET, Level: 2A, Subtype: Non-Small Cell Lung
      Cancer}
  - {Alteration: Y1003N, Gene: MET, Level: 2A, Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: 981_1028splice, Gene: MET, Level: 2A, Subtype: Non-Small Cell Lung
      Cancer}
  - {Alteration: Amplification, Gene: MET, Level: 2A, Subtype: Non-Small Cell Lung
      Cancer}
  - {Alteration: X1006_splice, Gene: MET, Level: 2A, Subtype: Non-Small Cell Lung
      Cancer}
  - {Alteration: X963_splice, Gene: MET, Level: 2A, Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: D1010N, Gene: MET, Level: 2A, Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: X1008_splice, Gene: MET, Level: 2A, Subtype: Non-Small Cell Lung
      Cancer}
  - {Alteration: D1010Y, Gene: MET, Level: 2A, Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: X1009_splice, Gene: MET, Level: 2A, Subtype: Non-Small Cell Lung
      Cancer}
  - *id032
  - *id020
  - {Alteration: Fusions, Gene: ROS1, Level: '1', Subtype: Non-Small Cell Lung Cancer}
  DCC-2618:
  - *id033
  - *id034
  - *id035
  - *id036
  - *id037
  - *id038
  - *id039
  - *id040
  DS-3032b:
  - &id082 {Alteration: Amplification, Gene: MDM2, Level: 3A, Subtype: Liposarcoma}
  Dabrafenib:
  - &id112 {Alteration: V600M, Gene: BRAF, Level: 2A, Subtype: Non-Small Cell Lung
      Cancer}
  - &id113 {Alteration: V600G, Gene: BRAF, Level: 2A, Subtype: Non-Small Cell Lung
      Cancer}
  - &id041 {Alteration: V600M, Gene: BRAF, Level: '1', Subtype: Melanoma}
  - &id042 {Alteration: V600K, Gene: BRAF, Level: '1', Subtype: Melanoma}
  - &id114 {Alteration: V600E, Gene: BRAF, Level: 2A, Subtype: Non-Small Cell Lung
      Cancer}
  - &id043 {Alteration: V600G, Gene: BRAF, Level: '1', Subtype: Melanoma}
  - &id115 {Alteration: V600D, Gene: BRAF, Level: 2A, Subtype: Non-Small Cell Lung
      Cancer}
  - &id116 {Alteration: V600R, Gene: BRAF, Level: 2A, Subtype: Non-Small Cell Lung
      Cancer}
  - &id044 {Alteration: V600R, Gene: BRAF, Level: '1', Subtype: Melanoma}
  - &id045 {Alteration: V600D, Gene: BRAF, Level: '1', Subtype: Melanoma}
  - &id046 {Alteration: V600E, Gene: BRAF, Level: '1', Subtype: Melanoma}
  - &id117 {Alteration: V600K, Gene: BRAF, Level: 2A, Subtype: Non-Small Cell Lung
      Cancer}
  Dabrafenib + Lapatinib:
  - {Alteration: V600K, Gene: BRAF, Level: '4', Subtype: Thyroid Cancer}
  - {Alteration: V600E, Gene: BRAF, Level: '4', Subtype: Thyroid Cancer}
  Dabrafenib + Trametinib:
  - {Alteration: V600D, Gene: BRAF, Level: '1', Subtype: Non-Small Cell Lung Cancer}
  - *id041
  - *id042
  - *id043
  - {Alteration: V600K, Gene: BRAF, Level: '1', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: V600G, Gene: BRAF, Level: '1', Subtype: Non-Small Cell Lung Cancer}
  - *id044
  - *id045
  - {Alteration: V600E, Gene: BRAF, Level: '1', Subtype: Non-Small Cell Lung Cancer}
  - *id046
  - {Alteration: V600R, Gene: BRAF, Level: '1', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: V600M, Gene: BRAF, Level: '1', Subtype: Non-Small Cell Lung Cancer}
  Dasatinib:
  - &id068 {Alteration: BCR-ABL1 Fusion, Gene: ABL1, Level: '1', Subtype: Acute Lymphoid
      Leukemia}
  - &id069 {Alteration: BCR-ABL1 Fusion, Gene: ABL1, Level: '1', Subtype: Chronic
      Myelogenous Leukemia}
  - {Alteration: D842V, Gene: PDGFRA, Level: 2A, Subtype: Gastrointestinal Stromal
      Tumor}
  Debio1347:
  - *id002
  - *id003
  - *id004
  - *id005
  - *id006
  - *id007
  - *id016
  - *id008
  - *id009
  - *id010
  - *id011
  - *id012
  - *id013
  - *id014
  - *id015
  - *id017
  Enasidenib:
  - {Alteration: R140Q, Gene: IDH2, Level: '1', Subtype: Acute Myeloid Leukemia}
  - {Alteration: R172S, Gene: IDH2, Level: '1', Subtype: Acute Myeloid Leukemia}
  - {Alteration: R172M, Gene: IDH2, Level: '1', Subtype: Acute Myeloid Leukemia}
  - {Alteration: R172K, Gene: IDH2, Level: '1', Subtype: Acute Myeloid Leukemia}
  - {Alteration: R172G, Gene: IDH2, Level: '1', Subtype: Acute Myeloid Leukemia}
  Entrectinib:
  - &id073 {Alteration: Fusions, Gene: NTRK3, Level: 3A, Subtype: All Solid Tumors}
  - &id074 {Alteration: Fusions, Gene: NTRK2, Level: 3A, Subtype: All Solid Tumors}
  - &id075 {Alteration: Fusions, Gene: NTRK1, Level: 3A, Subtype: All Solid Tumors}
  Erlotinib:
  - *id047
  - *id048
  - *id049
  - *id050
  - *id051
  - *id052
  - *id053
  - *id054
  - *id055
  - *id056
  - *id057
  - *id058
  - *id059
  - *id060
  - *id061
  - *id062
  - *id063
  - *id064
  - *id065
  Everolimus:
  - {Alteration: Oncogenic Mutations, Gene: TSC1, Level: 2A, Subtype: CNS Cancer}
  - {Alteration: Oncogenic Mutations, Gene: TSC1, Level: 2A, Subtype: Renal Cell Carcinoma}
  - {Alteration: Oncogenic Mutations, Gene: TSC2, Level: 2A, Subtype: CNS Cancer}
  - &id100 {Alteration: S2215F, Gene: MTOR, Level: '4', Subtype: Renal Clear Cell
      Carcinoma}
  - &id101 {Alteration: L2230V, Gene: MTOR, Level: '4', Subtype: Renal Clear Cell
      Carcinoma}
  - &id102 {Alteration: F1888L, Gene: MTOR, Level: '4', Subtype: Renal Clear Cell
      Carcinoma}
  - &id103 {Alteration: T1977K, Gene: MTOR, Level: '4', Subtype: Renal Clear Cell
      Carcinoma}
  - {Alteration: E2014K, Gene: MTOR, Level: 3A, Subtype: Bladder Cancer}
  - &id104 {Alteration: C1483F, Gene: MTOR, Level: '4', Subtype: Renal Clear Cell
      Carcinoma}
  Fulvestrant:
  - *id066
  GDC-0077:
  - *id001
  GDC-0994:
  - &id070 {Alteration: Oncogenic Mutations, Gene: KRAS, Level: '4', Subtype: All
      Tumors}
  GSK2636771:
  - *id067
  Gefitinib:
  - *id047
  - *id048
  - *id049
  - *id050
  - *id051
  - *id052
  - *id053
  - *id054
  - *id055
  - *id056
  - *id057
  - *id058
  - *id059
  - *id060
  - *id061
  - *id062
  - *id063
  - *id064
  - *id065
  Imatinib:
  - *id068
  - *id069
  - {Alteration: D816H, Gene: KIT, Level: 2A, Subtype: Melanoma}
  - {Alteration: D816F, Gene: KIT, Level: 2A, Subtype: Melanoma}
  - {Alteration: D816G, Gene: KIT, Level: 2A, Subtype: Melanoma}
  - {Alteration: V654A, Gene: KIT, Level: 2A, Subtype: Melanoma}
  - {Alteration: D816A, Gene: KIT, Level: 2A, Subtype: Melanoma}
  - {Alteration: Oncogenic Mutations, Gene: KIT, Level: 2A, Subtype: Melanoma}
  - {Alteration: T670I, Gene: KIT, Level: 2A, Subtype: Melanoma}
  - &id083 {Alteration: Oncogenic Mutations, Gene: KIT, Level: '1', Subtype: Gastrointestinal
      Stromal Tumor}
  - {Alteration: D816Y, Gene: KIT, Level: 2A, Subtype: Melanoma}
  - {Alteration: Exon 17 mutations, Gene: KIT, Level: 2A, Subtype: Melanoma}
  - {Alteration: D816V, Gene: KIT, Level: 2A, Subtype: Melanoma}
  - {Alteration: D816N, Gene: KIT, Level: 2A, Subtype: Melanoma}
  - {Alteration: D816E, Gene: KIT, Level: 2A, Subtype: Melanoma}
  - {Alteration: Fusions, Gene: PDGFRB, Level: '1', Subtype: Myelodysplasia}
  - {Alteration: Fusions, Gene: PDGFRB, Level: '1', Subtype: Dermatofibrosarcoma Protuberans}
  - {Alteration: Fusions, Gene: PDGFRB, Level: '1', Subtype: Myeloproliferative Neoplasm}
  - &id076 {Alteration: Oncogenic Mutations, Gene: PDGFRB, Level: '4', Subtype: All
      Tumors}
  - {Alteration: FIP1L1-PDGFRA Fusion, Gene: PDGFRA, Level: '1', Subtype: Leukemia}
  - {Alteration: Fusions, Gene: PDGFRA, Level: '1', Subtype: Myeloproliferative Neoplasm}
  - {Alteration: Fusions, Gene: PDGFRA, Level: '1', Subtype: Myelodysplasia}
  - {Alteration: Oncogenic Mutations, Gene: PDGFRA, Level: 2A, Subtype: Gastrointestinal
      Stromal Tumor}
  - {Alteration: D842V, Gene: PDGFRA, Level: R1, Subtype: Gastrointestinal Stromal
      Tumor}
  Ivosidenib:
  - {Alteration: R132Q, Gene: IDH1, Level: 3A, Subtype: Acute Myeloid Leukemia}
  - {Alteration: R132S, Gene: IDH1, Level: 3A, Subtype: Acute Myeloid Leukemia}
  - {Alteration: R132H, Gene: IDH1, Level: 3A, Subtype: Acute Myeloid Leukemia}
  - {Alteration: R132G, Gene: IDH1, Level: 3A, Subtype: Acute Myeloid Leukemia}
  - {Alteration: R132C, Gene: IDH1, Level: 3A, Subtype: Acute Myeloid Leukemia}
  JNJ-42756493:
  - *id002
  - *id003
  - *id004
  - *id005
  - *id006
  - *id007
  - *id016
  - *id008
  - *id009
  - *id010
  - *id011
  - *id012
  - *id013
  - *id014
  - *id015
  - *id017
  KO-947:
  - *id070
  - *id071
  LOXO-195:
  - {Alteration: G696A, Gene: NTRK3, Level: '4', Subtype: All Tumors}
  - {Alteration: G623R, Gene: NTRK3, Level: '4', Subtype: All Tumors}
  - {Alteration: G595R, Gene: NTRK1, Level: '4', Subtype: All Tumors}
  - {Alteration: G667C, Gene: NTRK1, Level: '4', Subtype: All Tumors}
  LTT462:
  - *id071
  - *id018
  LY3214996:
  - *id070
  Lapatinib:
  - *id072
  Lapatinib + Trastuzumab:
  - *id072
  Larotrectinib:
  - *id073
  - *id074
  - *id075
  Neratinib:
  - {Alteration: Oncogenic Mutations, Gene: ERBB2, Level: 3A, Subtype: Non-Small Cell
      Lung Cancer}
  - {Alteration: Oncogenic Mutations, Gene: ERBB2, Level: 3A, Subtype: Breast Cancer}
  Nilotinib:
  - *id069
  - *id076
  Niraparib:
  - &id084 {Alteration: Oncogenic Mutations, Gene: BRCA2, Level: '1', Subtype: Ovarian
      Cancer}
  - &id085 {Alteration: Oncogenic Mutations, Gene: BRCA1, Level: '1', Subtype: Ovarian
      Cancer}
  Nivolumab:
  - {Alteration: Microsatellite Instability-High, Gene: Other Biomarkers, Level: '1',
    Subtype: Colorectal Cancer}
  Olaparib:
  - {Alteration: Oncogenic Mutations, Gene: BRCA2, Level: 2A, Subtype: Ovarian Cancer}
  - {Alteration: Oncogenic Mutations, Gene: BRCA1, Level: 2A, Subtype: Ovarian Cancer}
  - {Alteration: Truncating Mutations, Gene: ATM, Level: '4', Subtype: Prostate Cancer}
  - {Alteration: N2875K, Gene: ATM, Level: '4', Subtype: Prostate Cancer}
  - {Alteration: R3008C, Gene: ATM, Level: '4', Subtype: Prostate Cancer}
  Osimertinib:
  - {Alteration: T790M, Gene: EGFR, Level: '1', Subtype: Non-Small Cell Lung Cancer}
  PF-03084014:
  - {Alteration: Gain-of-function Mutations, Gene: NOTCH1, Level: '4', Subtype: All
      Tumors}
  Palbociclib:
  - *id077
  - *id078
  Panitumumab:
  - *id079
  - *id080
  - *id081
  Pembrolizumab:
  - {Alteration: Microsatellite Instability-High, Gene: Other Biomarkers, Level: '1',
    Subtype: All Solid Tumors}
  Pertuzumab + Trastuzumab:
  - *id072
  Ponatinib:
  - *id076
  RG7112:
  - *id082
  RTK-Inhibitor + Trametinib:
  - {Alteration: G466A, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: D594A, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: F595L, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: G466E, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: G466V, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: N581I, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: N581S, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: D594N, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: D594G, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: G469E, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: S467L, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: G596R, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: G596D, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: D287H, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: N581I, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: V459L, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: G466E, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: G466A, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: D594H, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: N581S, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: D594H, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: F595L, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: D594A, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: G596D, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: D287H, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: G466V, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: V459L, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: G469E, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: D594G, Gene: BRAF, Level: '4', Subtype: Colorectal Cancer}
  - {Alteration: G596R, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: S467L, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  - {Alteration: D594N, Gene: BRAF, Level: '4', Subtype: Non-Small Cell Lung Cancer}
  Regorafenib:
  - *id083
  - &id093 {Alteration: T670I, Gene: KIT, Level: '1', Subtype: Gastrointestinal Stromal
      Tumor}
  - {Alteration: Exon 17 mutations, Gene: KIT, Level: '1', Subtype: Gastrointestinal
      Stromal Tumor}
  - &id096 {Alteration: V654A, Gene: KIT, Level: '1', Subtype: Gastrointestinal Stromal
      Tumor}
  - *id079
  Rucaparib:
  - *id084
  - *id085
  Ruxolitinib:
  - {Alteration: PCM1-JAK2 Fusion, Gene: JAK2, Level: 3A, Subtype: Leukemia}
  Selumetinib + Radioiodine Uptake Therapy:
  - {Alteration: Oncogenic Mutations, Gene: NRAS, Level: 3A, Subtype: Thyroid Cancer}
  Serabelisib:
  - *id001
  Sonidegib:
  - &id118 {Alteration: Truncating Mutations, Gene: PTCH1, Level: 3A, Subtype: 'Skin
      Cancer, Non-Melanoma'}
  - {Alteration: Truncating Mutations, Gene: PTCH1, Level: 3A, Subtype: Embryonal
      Tumor}
  Sorafenib:
  - &id086 {Alteration: D816G, Gene: KIT, Level: 2A, Subtype: Thymic Tumor}
  - &id087 {Alteration: D816H, Gene: KIT, Level: 2A, Subtype: Thymic Tumor}
  - &id088 {Alteration: Oncogenic Mutations, Gene: KIT, Level: 2A, Subtype: Thymic
      Tumor}
  - &id089 {Alteration: D816V, Gene: KIT, Level: 2A, Subtype: Thymic Tumor}
  - &id090 {Alteration: D816A, Gene: KIT, Level: 2A, Subtype: Thymic Tumor}
  - &id091 {Alteration: T670I, Gene: KIT, Level: 2A, Subtype: Thymic Tumor}
  - &id092 {Alteration: D816Y, Gene: KIT, Level: 2A, Subtype: Thymic Tumor}
  - &id094 {Alteration: Exon 17 mutations, Gene: KIT, Level: 2A, Subtype: Thymic Tumor}
  - &id095 {Alteration: D816F, Gene: KIT, Level: 2A, Subtype: Thymic Tumor}
  - {Alteration: Exon 17 mutations, Gene: KIT, Level: 2A, Subtype: Gastrointestinal
      Stromal Tumor}
  - &id097 {Alteration: D816E, Gene: KIT, Level: 2A, Subtype: Thymic Tumor}
  - &id098 {Alteration: D816N, Gene: KIT, Level: 2A, Subtype: Thymic Tumor}
  - &id099 {Alteration: V654A, Gene: KIT, Level: 2A, Subtype: Thymic Tumor}
  - {Alteration: Oncogenic Mutations, Gene: ARAF, Level: 3A, Subtype: Histiocytosis}
  - {Alteration: Oncogenic Mutations, Gene: ARAF, Level: 3A, Subtype: Non-Small Cell
      Lung Cancer}
  - {Alteration: FLT3 internal tandem duplications, Gene: FLT3, Level: 3A, Subtype: Acute
      Myeloid Leukemia}
  Sunitinib:
  - *id086
  - *id087
  - *id088
  - *id089
  - *id083
  - *id090
  - *id091
  - *id092
  - *id093
  - *id094
  - *id095
  - *id096
  - *id097
  - *id098
  - *id099
  TK216:
  - {Alteration: Fusions, Gene: EWSR1, Level: '4', Subtype: Soft Tissue Sarcoma}
  Taselisib:
  - *id001
  Taselisib + Fulvestrant:
  - *id001
  Tazemetostat:
  - {Alteration: Oncogenic Mutations, Gene: EZH2, Level: '4', Subtype: Diffuse Large
      B-Cell Lymphoma}
  Temsirolimus:
  - *id100
  - *id101
  - *id102
  - *id103
  - *id104
  Tipifarnib:
  - {Alteration: Oncogenic Mutations, Gene: HRAS, Level: 3A, Subtype: Head and Neck
      Squamous Cell Carcinoma}
  Trametinib:
  - *id105
  - *id041
  - *id042
  - {Alteration: G469R, Gene: BRAF, Level: '4', Subtype: Melanoma}
  - *id106
  - {Alteration: L597Q, Gene: BRAF, Level: 3A, Subtype: Melanoma}
  - {Alteration: L597R, Gene: BRAF, Level: 3A, Subtype: Melanoma}
  - *id043
  - *id107
  - {Alteration: p61BRAF-V600E, Gene: BRAF, Level: '4', Subtype: Melanoma}
  - {Alteration: L597V, Gene: BRAF, Level: 3A, Subtype: Melanoma}
  - {Alteration: G464E, Gene: BRAF, Level: '4', Subtype: Melanoma}
  - {Alteration: G469A, Gene: BRAF, Level: '4', Subtype: Melanoma}
  - *id044
  - *id045
  - *id046
  - {Alteration: G469V, Gene: BRAF, Level: '4', Subtype: Melanoma}
  - {Alteration: L597S, Gene: BRAF, Level: 3A, Subtype: Melanoma}
  - {Alteration: K601E, Gene: BRAF, Level: 3A, Subtype: Melanoma}
  - {Alteration: G464V, Gene: BRAF, Level: '4', Subtype: Melanoma}
  - *id018
  - *id108
  - *id109
  - *id110
  - *id111
  Trastuzumab:
  - {Alteration: Amplification, Gene: ERBB2, Level: '1', Subtype: Esophagogastric
      Cancer}
  - *id072
  Vandetanib:
  - {Alteration: Fusions, Gene: RET, Level: 3A, Subtype: Non-Small Cell Lung Cancer}
  Vemurafenib:
  - *id112
  - *id113
  - *id041
  - *id042
  - *id114
  - {Alteration: V600M, Gene: BRAF, Level: '1', Subtype: Histiocytosis}
  - {Alteration: V600R, Gene: BRAF, Level: '1', Subtype: Histiocytosis}
  - *id043
  - {Alteration: V600D, Gene: BRAF, Level: '1', Subtype: Histiocytosis}
  - *id115
  - {Alteration: V600E, Gene: BRAF, Level: '1', Subtype: Histiocytosis}
  - *id116
  - *id044
  - *id045
  - *id046
  - {Alteration: V600K, Gene: BRAF, Level: '1', Subtype: Histiocytosis}
  - *id117
  - {Alteration: V600G, Gene: BRAF, Level: '1', Subtype: Histiocytosis}
  Vemurafenib + Cobimetinib:
  - *id041
  - *id042
  - *id043
  - *id044
  - *id045
  - *id046
  Vismodegib:
  - *id118
